{"id":132308,"date":"2026-02-06T14:10:52","date_gmt":"2026-02-06T13:10:52","guid":{"rendered":"https:\/\/lightweb.dev\/s\/key2compliance\/?p=132308"},"modified":"2026-04-02T12:00:05","modified_gmt":"2026-04-02T10:00:05","slug":"quality-risk-management-powered-by-people","status":"publish","type":"post","link":"https:\/\/lightweb.dev\/s\/key2compliance\/news\/quality-risk-management-powered-by-people\/","title":{"rendered":"Quality Risk Management, Powered by People"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"Afifa\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Nadia Ragnvald Caspersen
Senior consultant, Medical Device QA\/RA – GBA Key2Compliance<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t
\n\t\t\t\t\t

Building better systems through respect, teamwork, and ongoing improvement<\/h2>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Quality management\u00a0isn\u2019t\u00a0just about systems\u00a0and standards\u2014it\u2019s\u00a0about people. Every device we help bring to market is\u00a0ultimately used\u00a0by someone who trusts it with their wellbeing.\u00a0<\/p>

As QA\/RA\u00a0professionals, our responsibility\u00a0goes far beyond compliance;\u00a0it\u2019s\u00a0about safeguarding lives, supporting clinicians, and earning the trust of patients and their families.\u00a0<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t

Risk Management in Quality Management Systems<\/h2>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

In the realm of Quality Management Systems (QMS), effective risk management encompasses the identification, assessment, and control of risks associated with both products and processes throughout their entire lifecycle. The focus includes not only patient safety but also the quality and reliability of the product itself. A poorly executed risk management system may\u00a0<\/span>fail to<\/span>\u00a0<\/span>identify<\/span>\u00a0potential dangers, leading to device malfunctions, patient harm, or substantial financial repercussions.\u00a0<\/span><\/span><\/p>

Recognising and evaluating all potential risks is a complicated endeavour that\u00a0<\/span>necessitates<\/span>\u00a0a collaborative approach, going beyond the Quality Assurance (QA) department alone, and requires a comprehensive understanding of the product and its intended use.<\/span><\/span>\u00a0<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t

Collaborative Approach <\/h2>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Effective risk management is a team effort that thrives on empathy and understanding. By listening to the experiences of clinicians, engineers, and even patients, we gain insights that technical data alone cannot provide. This collaborative spirit ensures that our risk assessments reflect real-world scenarios and genuine human needs\u2014not just theoretical hazards.\u00a0<\/p>

One major challenge in risk management is\u00a0anticipating\u00a0all\u00a0possible risks\u00a0that could\u00a0emerge\u00a0during the product lifecycle. This requires a grasp of the product\u2019s clinical applications, the patient demographic, the environment in which the device will\u00a0operate, and any associated hazards. Organisations must adopt a systematic method and assemble a team with a varied skill set\u2014spanning clinical, engineering, regulatory, and quality domains\u2014to perform thorough risk assessments.\u00a0<\/p>

Risk management is an evolving process that should be regularly updated in response to changes in technology, market conditions, and trends. It is crucial for management to recognise their pivotal role in this field, as they\u00a0possess\u00a0the authority to\u00a0allocate\u00a0the necessary time and resources for this essential task.\u00a0<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t

Risk-Based Methodology <\/h2>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Given the various roles within the organisation, it is vital to\u00a0establish\u00a0the\u00a0appropriate processes, their intended applications, the sequence of their execution, and their interactions with other processes. The level of oversight for these processes must be rooted in an understanding of risk. Organisations should\u00a0identify\u00a0the risks that could impair the effective and compliant functioning of their QMS.\u00a0<\/p>

When recognising risks, the organisation should prioritise the prevention or mitigation of undesirable outcomes through risk reduction and preventive measures. This approach\u00a0represents\u00a0a commitment to a risk-based strategy, which should be applied across all\u00a0processes\u00a0integral to the QMS.\u00a0<\/p>

Throughout the ISO 13485 standard, the concept of risk pertains specifically to the safety and efficacy of medical devices in addition to fulfilling regulatory obligations, rather than financial risks or business performance concerns. This is explicitly mentioned in clause 7.1, with clause 4.1.2(b) emphasising that a risk-based approach must also be integrated into relevant processes within your QMS. These processes must be\u00a0identified\u00a0and managed through your risk-based controls.\u00a0<\/p>

The emphasis lies in incorporating a risk-based strategy within processes where failures could lead to unsafe products or those that do not function as intended, while also ensuring compliance with regulatory standards. ISO 13485:2016 does not mandate formal risk management for\u00a0identifying\u00a0risks within QMS processes themselves; however, it does call for the execution of a risk-based approach within those processes. The organisation has the flexibility to choose the methods that best suit its needs,\u00a0as long as\u00a0they are justified and adequately described.\u00a0<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t

Strategic Considerations <\/h2>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Selecting the right risk management tools\u00a0isn\u2019t\u00a0just a technical decision\u2014it\u2019s\u00a0about understanding the unique challenges faced by those who use,\u00a0maintain, and rely on our products. By considering the perspectives of everyone involved, we tailor our approach to fit not only the device, but also the people and environments it serves.\u00a0<\/p>

At a strategic level, various tools, such as SWOT (Strengths, Weaknesses, Opportunities, Threats) analysis, PESTEL (Political, Economic, Socio-Cultural, Technological, Environmental, Legal Factors), and Porter\u2019s Five Forces analysis, can be utilised.\u00a0<\/p>

A straightforward approach might involve posing \u201cwhat if\u201d scenarios, while brainstorming techniques can also serve as effective methods for illustrating a risk-based approach. Some techniques are more suitable for detailed analysis, such as Failure Mode and Effects Analysis (FMEA), Failure Mode, Effects and Criticality Analysis (FMECA), Hazard Analysis and Critical Control Points (HACCP), along with root cause and decision analysis tools, including Fault Tree Analysis (FTA) and 5 Whys.\u00a0<\/p>

It is important to select the methods or tools you will implement and to\u00a0establish, execute, and\u00a0maintain\u00a0the necessary documentation for their usage. It quickly becomes\u00a0apparent\u00a0that \u201cone size fits all\u201d does not apply here; the best method often depends on the specific situation. Educating the entire organisation on every available risk management tool is impractical; thus, it is advisable to focus on a select few tools and implement them effectively within your organisation.\u00a0<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t

Execution <\/h2>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

When we improve our processes, our goal is always to create safer, more reliable outcomes for real people. Each enhancement to our QMS is a step towards better patient experiences, smoother clinical workflows, and greater peace of mind for everyone who interacts with our products.\u00a0<\/p>

In addressing risks, organisations should adopt a risk-based strategy for the establishment, implementation, maintenance, and improvement of the QMS and its associated processes\u00a0in order to:\u00a0<\/p>